Autism spectrum disorder (ASD) and autism are both general terms for a group of complex developmental disorders. They are characterized by impaired social interaction and communication and well as altered behavior. For many years, ASD was considered to be a rare pathology occurring in 1 out of 2,000 children. However, in 2014, the US Federal Centers for Disease Control estimates that 1 in 68 children in the US has been diagnosed with ASD which is more than a 500 percent increase in the nationwide rate of autism.
Such a dramatic increase in the number of affected children across the globe, is cause for great worry among worldwide scientists.
Recently, Human Microbiology Institute researchers have made amazing advances in understanding the mechanisms that may trigger ASD and affect the severity of autism symptoms.
HMI scientists are currently studying the underlying particularities of microbiota in autistic people and the role of its alterations in ASD. This research will provide insights that may facilitate the development of new therapeutic strategies and compounds for these disorders and try to evaluate strategies that may make these conditions reversible.